Clinical Trials

NCT06259071 | RECRUITING
1000 participants

MuSK Myasthenia 1000 Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-05
Start Date:
2023-08-23
Completion:
2027-08-23
Conditions
  • Myasthenia Gravis
  • MuSK MG
  • MuSK Myasthenia Gravis
No Results Yet
NCT06182995 | ACTIVE_NOT_RECRUITING | NA
109 participants

Anticipating Decline and Providing Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2024-03-08
Completion:
2026-03-01
Conditions
  • Cognitive Impairment
  • Dementia
  • Post ICU Syndrome
  • Critical Illness
  • Cognitive Impairment, Mild
Interventions
  • BEHAVIORAL
No Results Yet
NCT06139523 | RECRUITING
30 participants

Optimize Pediatric OCT Imaging

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-05
Start Date:
2024-01-24
Completion:
2027-07-31
Conditions
  • Retinal Disease
  • Glaucoma
  • Optic Nerve Diseases
Interventions
  • DEVICE
No Results Yet
NCT06138405 | RECRUITING | NA
5808 participants

Dental-Child Interaction Training

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2026-04-03
Completion:
2028-08-31
Conditions
  • Behavior and Behavior Mechanisms
  • Child Behavior
Interventions
  • BEHAVIORAL
No Results Yet
NCT06124157 | RECRUITING | PHASE2
222 participants

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2025-05-30
Completion:
2030-12-01
Conditions
  • B Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
  • RADIATION
No Results Yet
NCT06116110 | RECRUITING
150 participants

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-05
Start Date:
2024-05-15
Completion:
2041-12-01
Conditions
  • Non Hodgkin Lymphoma
  • Refractory Diffuse Large B Cell Lymphoma (DLBCL)
  • Relapsed Diffuse Large B Cell Lymphoma
  • High Grade B-cell Lymphoma
  • Central Nervous System Lymphoma
  • Primary Mediastinal B-cell Lymphoma (PMBCL)
Interventions
  • OTHER
No Results Yet
NCT06065748 | RECRUITING | PHASE3
1050 participants

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2023-12-11
Completion:
2027-02-19
Conditions
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Interventions
  • DRUG
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page